» Authors » Madeleine L Drent

Madeleine L Drent

Explore the profile of Madeleine L Drent including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 88
Citations 1347
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Hoeven L, Slagboom T, Malekzadeh A, Hoogmoed J, Drent M, Aronica E, et al.
J Clin Endocrinol Metab . 2025 Feb; PMID: 39982832
Context: Immunohistochemistry (IHC) of cell lineage-specific transcription factors (TFs) has been added to the histopathological classification of pituitary adenomas since 2017, resulting in new histopathological subtypes of TF+/hormone- non-functioning pituitary...
2.
Slagboom T, Boertien T, Reitsma S, Bisschop P, Fliers E, Baaijen J, et al.
World Neurosurg . 2025 Feb; 196:123789. PMID: 39955050
Objective: Both tinnitus and sellar masses are common disorders in the general population and sometimes occur together. However, little is known about their relationship. We investigated the prevalence, clinical aspects,...
3.
van Andel M, van Schoor N, Korten N, Heijboer A, Drent M
Psychoneuroendocrinology . 2024 Sep; 170:107190. PMID: 39305810
Background: Leptin and ghrelin have been linked to depressive symptoms in older adults. There is a large overlap between depression and anxiety in this group. It is unclear whether the...
4.
Slagboom T, van Bunderen C, van der Lely A, Drent M
Pituitary . 2024 Aug; 27(5):590-604. PMID: 39215905
Purpose: Patients with hypopituitarism are at increased cardiovascular risk, in part because of growth hormone deficiency (GHD), but probably also because of the overuse of glucocorticosteroids in concomitant adrenal insufficiency...
5.
Boertien T, Drent M, Booij J, Majoie C, Stokkel M, Hoogmoed J, et al.
Lancet Reg Health Eur . 2024 Jul; 42:100923. PMID: 39070749
Background: No established medical treatment options currently exist for patients with non-functioning pituitary macroadenoma (NFPMA). Somatostatin analogues may prevent tumour growth, but randomised controlled trials are lacking. somatostatin receptor assessment...
6.
Slagboom T, Boertien T, Bisschop P, Fliers E, Baaijen J, Hoogmoed J, et al.
Endocrinol Diabetes Metab . 2024 Jul; 7(4):e496. PMID: 39001600
Introduction: Sellar masses are common intracranial neoplasms. Their clinical manifestations vary widely and include headache. We aimed to determine whether the prevalence and characteristics of headache in patients with sellar...
7.
de Laat J, van der Horst-Schrivers A, Appelman-Dijkstra N, Bisschop P, Dreijerink K, Drent M, et al.
J CME . 2024 Jun; 13(1):2360137. PMID: 38831939
Entrustable Professional Activities (EPAs) are an important tool to support individualisation of medical training in a competency-based setting and are increasingly implemented in the clinical speciality training for endocrinologist. This...
8.
Slagboom T, van der Lely A, Drent M, van Bunderen C
Eur J Endocrinol . 2024 May; 190(6):434-445. PMID: 38798228
Objective: Given the previously identified sex differences in cardiovascular (CV) morbidity and mortality in patients with growth hormone deficiency (GHD) receiving GH replacement therapy (GHRT), our aim is to investigate...
9.
Slagboom T, van Bunderen C, de Vries R, Bisschop P, Drent M
Pituitary . 2023 May; 26(4):319-332. PMID: 37210433
Objective: Diagnostic delay is high in acromegaly and leads to increased morbidity and mortality. The aim of this study is to systematically assess the most prevalent clinical signs, symptoms and...
10.
Slagboom T, Stenvers D, van de Giessen E, Roosendaal S, de Win M, Bot J, et al.
J Clin Med . 2023 Apr; 12(8). PMID: 37109254
The definitive diagnosis of Cushing's disease (CD) in the presence of pituitary microadenoma remains a continuous challenge. Novel available pituitary imaging techniques are emerging. This study aimed to provide a...